SCHEMBL19976800

SCHEMBL19976800

CC(C)(C)CN/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2ccc(C(F)(F)F)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.43
MAP2K4 P45985 4/20 0.42
MAPK1 P28482 3/20 0.42
MAPK6 Q16659 3/20 0.42
MAPKAPK3 Q16644 2/20 0.42
TRPA1 O75762 2/20 0.42
HDAC6 Q9UBN7 1/20 0.40
MAPK8 P45983 3/20 0.39
MAPK10 P53779 2/20 0.39
FADS1 O60427 1/20 0.39
NTRK1 P04629 3/20 0.38
MAPKAPK5 Q8IW41 2/20 0.37
AURKB Q96GD4 2/20 0.37
PLK4 O00444 1/20 0.37
MAPK13 O15264 1/20 0.37
DAPK3 O43293 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
CDK1 P06493 1/20 0.37
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976854 0.89 GSK3B (0.42) GSK3BMAP2K4MAPK1MAPK6MAPKAPK3
SCHEMBL19976736 0.88 MAP2K4 (0.44) GSK3BMAP2K4MAPK1MAPK6MAPKAPK3
SCHEMBL19976815 0.88 GSK3B (0.44) GSK3BMAP2K4MAPK1MAPK6MAPKAPK3
SCHEMBL19976757 0.87 HDAC6 (0.39) GSK3BHDAC6MAPK8MAPK10MAPKAPK5
SCHEMBL19976888 0.87 GSK3B (0.51) GSK3BMAP2K4MAPK1MAPK6TRPA1
SCHEMBL19976762 0.84 MAP2K4 (0.40) GSK3BMAP2K4MAPK1MAPK6MAPKAPK3
SCHEMBL19976767 0.82 GSK3B (0.51) GSK3BMAP2K4MAPK1MAPK6TRPA1
SCHEMBL19976812 0.81 GSK3B (0.51) GSK3BMAP2K4MAPK1MAPK6TRPA1
SCHEMBL19976725 0.81 GSK3B (0.52) GSK3BMAP2K4MAPK1MAPK6MAPKAPK3
SCHEMBL19976886 0.79 GSK3B (0.43) GSK3BMAP2K4MAPK1MAPK6HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed